Moderna, Inc. (MRNA) stock
MRNANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 5/30537% above fair value
$196.79−10.01 (-4.84%)
Close on Nov 18, 2026Market cap $78.57BP/E –Yield –
Moderna market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Moderna's market cap was $99.23B on Nov 11, 2026, against $10.16B a year earlier. Over the last 5 years it ranged from $9.37B to $102.86B, with a median of $40.71B.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $99.23B | +760.6% |
| 2025 | Dec 31, 2025 | $11.53B | -28.0% |
| 2024 | Dec 31, 2024 | $16.01B | -57.8% |
| 2023 | Dec 29, 2023 | $37.89B | -45.5% |
| 2022 | Dec 30, 2022 | $69.51B | -32.4% |
| 2021 | Dec 31, 2021 | $102.86B | +149.0% |
| 2020 | Dec 31, 2020 | $41.31B | +535.1% |
| 2019 | Dec 31, 2019 | $6.50B | +553.2% |
| 2018 | Dec 31, 2018 | $995.71M | – |
See a number that looks wrong?